NEW YORK (AP) — NEW YORK (AP) — Immunic, Inc. (IMUX) on Tuesday reported a loss of $34.1 million in its second quarter.
The New York-based company said it had a loss of 80 cents per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.24 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMUX at https://www.zacks.com/ap/IMUX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
